<DOC>
	<DOCNO>NCT02058550</DOCNO>
	<brief_summary>This randomize , pilot phase I trial study whether phone email reminder increase vaginal dilator use patient endometrial , cervical , vaginal cancer undergo brachytherapy . Brachytherapy type internal radiation use radioactive material place directly near tumor kill tumor cell . A reminder program may help increase use vaginal dilator decrease long-term side effect follow brachytherapy .</brief_summary>
	<brief_title>Phone Email Reminder Increasing Vaginal Dilator Use Patients With Gynecologic Cancers Undergoing Brachytherapy</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Evaluate whether vaginal dilator adherence improve additional reminder phone call and/or email reminder survey . SECONDARY OBJECTIVES : I . Evaluate whether difference length vaginal canal non-intervention intervention group . Evaluate rate gynecologic , urinary , gastrointestinal toxicity . OUTLINE : Patients randomize 1 3 arm . ARM I : Patients receive additional reminder . ARM II : Patients receive reminder email survey every 2 week 1 year complete radiation . ARM III : Patients receive reminder email survey Arm I 4 additional phone call 4-8 week , 3-5 month , 7-8 month , 10-11 month first year follow-up . After completion study , patient follow 10-14 week , 5-7 month , 8-10 month , 11-13 month , 15-17 month , 19-21 month , 23-25 month post treatment .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<criteria>Patients gynecologic cancer undergo vaginal brachytherapy part treatment Patients previously receive pelvic external beam radiation brachytherapy . Patients may enrol undergoing vaginal brachytherapy radiation treatment . Patients life expectancy least 1 year No Eastern Cooperative Oncology Group ( ECOG ) Karnofsky performance status requirement No organ marrow function requirement Ability understand willingness sign write informed consent document Patients receive prior pelvic external beam radiation brachytherapy exclude No restriction regard use investigational agent No exclusion requirement due comorbid disease intercurrent illness No investigational agent , exclusion requirement regard history allergic reaction attribute compound similar chemical biologic composition investigational agent device No exclusion criterion relate concomitant medication No exclusion criterion pregnant nursing patient participate study ( Of note , pregnant patient treat vaginal brachytherapy , requirement enrol study )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>